Human umbilical cord Wharton's jelly stem cells: Immune property genes assay and effect of transplantation on the immune cells of heart failure patients

Cellular Immunology

Volumn 276, Issue 1-2, 2012, Pages 83-90

  Chen, Haiying ^a,b   Zhang, Ningkun ^a   Li, Tianchang ^a   Guo, Jianwei ^a   Wang, Zhiguo ^a   Yang, Ming ^a   Gao, Lianru ^a  

^a NAVY GENERAL HOSPITAL   (China)

^b The 210th Hospital of PLA   (China)

Author keywords

Cell transplantation; Immunity; Immunomodulation; Stem cells; Wharton's jelly

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD40 LIGAND; CD86 ANTIGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; HEME OXYGENASE 1; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DRB1 ANTIGEN; HLA DRB3 ANTIGEN; HLA DRB4 ANTIGEN; HLA E ANTIGEN; HLA F ANTIGEN; HLA G ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROGRAMMED DEATH 1 LIGAND 1; PROSTAGLANDIN E SYNTHASE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ARTICLE; GENE EXPRESSION; HEART FAILURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOMODULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; REFRACTORY ANEMIA; STEM CELL TRANSPLANTATION; T LYMPHOCYTE SUBPOPULATION; UMBILICAL CORD; WHARTON JELLY;

ANTIGENS, CD; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; HEART FAILURE; HLA ANTIGENS; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTES; UMBILICAL CORD; WHARTON JELLY;

EID: 84863863202     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2012.03.012     Document Type: Article

References (47)

1. Boyle A.J., McNiece I.K., Hare J.M. Mesenchymal stem cell therapy for cardiac repair. Methods Mol. Biol. 2010, 660:65-84.
2. Gong W., Han Z., Zhao H., Wang Y., Wang J., Zhong J., Wang B., Wang S., Wang Y., Sun L., Han Z. Banking human umbilical cord derived mesenchymal stromal cells for clinical use. Cell Transplant 2012, 21:207-216.
3. Chen M.Y., Lie P.C., Li Z.L., Wei X. Endothelial differentiation of Wharton's jelly-derived mesenchymal stem cells in comparison with bone marrow-derived mesenchymal stem cells. Exp. Hematol. 2009, 37:629-640.
4. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., Deans R., Keating A., Prockop Dj., Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
5. La Rocca G., Anzalone R., Corrao S., Magno F., Loria T., Lo Iacono M., Di Stefano A., Giannuzzi P., Marasà L., Cappello T., Zummo G., Farina F. Isolation and characterization of Oct-4+/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem. Cell Biol. 2009, 131:267-282.
6. Weiss M.L., Anderson C., Medicetty S., Seshareddy K.B., Weiss R.J., VanderWerff I., Troyer D., McIntosh K.R. Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 2008, 26:2865-2874.
7. Fu Y.S., Cheng Y.C., Lin M.Y., Cheng H., Chu P.M., Chou S.C., Shih Y.H., Ko M.H., Sung M.S. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 2006, 24:115-124.
8. Medicetty S., Bledsoe A.R., Fahrenholtz C.B., Troyer D., Weiss M.L. Transplantation of pig stem cells into rat brain: proliferation during the first 8weeks. Exp. Neurol. 2004, 190:32-41.
9. Weiss M.L., Mitchell K.E., Hix J.E., Medicetty S., El-Zarkouny S.Z., Grieger D., Troyer D.L. Transplantation of porcine umbilical cord matrix cells into the rat brain. Exp. Neurol. 2003, 182:288-299.
10. Liao W., Xie J., Zhong J., Liu Y., Du L., Zhou B., Xu J., Liu P., Yang S., Wang J., Han Z., Han Z.C. Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation 2009, 87:350-359.
11. Wu K.H., Zhou B., Lu S.H., Feng B., Yang S.G., Du W.T., Gu D.S., Han Z.C., Liu Y.L. In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J. Cell. Biochem. 2007, 100:608-616.
12. Azari O., Babaei H., Derakhshanfar A., Nematollahi-Mahani S.N., Poursahebi R., Moshrefi M. Effects of transplanted mesenchymal stem cells isolated from Wharton's jelly of caprine umbilical cord on cutaneous wound healing; histopathological evaluation. Vet. Res. Commun. 2011, 35:211-222.
13. Cho P.S., Messina D.J., Hirsh E.L., Chi N., Goldman S.N., Lo D.P., Harris I.R., Popma S.H., Sachs D.H., Huang C.A. Immunogenicity of umbilical cord tissue derived cells. Blood 2008, 111:430-438.
14. Wang Y., Han Z.B., Ma J., Zuo C., Geng J., Gong W., Sun Y., Li H., Wang B., Zhang L., He Y., Han Z.C. A toxicity study of multiple-administration human umbilicalcord mesenchymal stem cells in cynomolgus monkeys. Stem Cells Dev. 2011, Nov 22 [Epub ahead of print].
15. Ishitani A., Sageshima N., Hatake K. The involvement of HLA-E and -F in pregnancy. J. Reprod. Immunol. 2006, 69:101-113.
16. Ishitani A., Sageshima N., Lee N., Dorofeeva N., Hatake K., Marquardt H., Geraghty D.E. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J. Immunol. 2003, 171:1376-1384.
17. Blaschitz A., Hutter H., Dohr G. HLA Class I protein expression in the human placenta. Early Pregnancy 2001, 5:67-69.
18. Le Bouteiller P. HLA-G in the human placenta: expression and potential functions. Biochem. Soc. Trans. 2000, 28:208-212.
19. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J., Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc. Natl. Acad. Sci. USA 1997, 94:11520-11525.
20. Riteau B., Moreau P., Menier C., Khalil-Daher I., Khosrotehrani K., Bras-Goncalves R., Paul P., Dausset J., Rouas-Freiss N., Carosella E.D. Characterization of HLA-G1, -G2, -G3, and -G4 isoforms transfected in a human melanoma cell line. Transplant. Proc. 2001, 33:2360-2364.
21. Fanchin R., Gallot V., Rouas-Freiss N., Frydman R., Carosella E.D. Implication of HLA-G in human embryo implantation. Hum. Immunol. 2007, 68:259-263.
22. Lee N., Llano M., Carretero M., Ishitani A., Navarro F., López-Botet M., Geraghty D.E. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 1998, (95):5199-5204.
23. Crew M.D., Cannon M.J., Phanavanh B., Garcia-Borges C.N. An HLA-E single chain trimer inhibits human NK cell reactivity towards porcine cells. Mol. Immunol. 2005, 42:1205-1214.
24. Najar M., Raicevic G., Boufker H.I., Fayyad-Kazan H., De Bruyn C., Meuleman N., Bron D., Toungouz M., Lagneaux L. Adipose-tissue-derived and Wharton's jelly-derived mesenchymal stromal cells suppress lymphocyte responses by secreting leukemia inhibitory factor. Tissue Eng. A 2010, 16:3537-3546.
25. Cutler A.J., Limbani V., Girdlestone J., Navarrete C.V. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. J. Immunol. 2010, 185:6617-6623.
26. Zhou C., Yang B., Tian Y., Jiao H., Zheng W., Wang J., Guan F. Immunomodulatory effect of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on lymphocytes. Cell. Immunol. 2011, 272:33-38.
27. Chen K., Wang D., Du W.T., Han Z.B., Ren H., Chi Y., Yang S.G., Zhu D., Bayard F., Han Z.C. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin. Immunol. 2010, 135:448-458.
28. Girdlestone J., Limbani V.A., Cutler A.J., Navarrete C.V. Efficient expansion of mesenchymal stromal cells from umbilical cord under low serum conditions. Cytotherapy 2009, 11:738-748.
29. Shi Y., Hu G., Su J., Li W., Chen Q., Shou P., Xu C., Chen X., Huang Y., Zhu Z., Huang X., Han X., Xie N., Ren G. Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair. Cell Res. 2010, 20:510-518.
30. Groh M.E., Maitra B., Szekely E., Koç O.N. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp. Hematol. 2005, 33:928-934.
31. Di Nicola M., Carlo-Stella C., Magni M., Milanesi M., Longoni P.D., Matteucci P., Grisanti S., Gianni A.M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002, 99:3338-3343.
32. English K., Ryan J.M., Tobin L., Murphy M.J., Barry F.P., Mahon B.P. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(High) forkhead box P3+ regulatory T cells. Clin. Exp. Immunol. 2009, 156:149-160.
33. Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005, 105:1815-1822.
34. Chabannes D., Hill M., Merieau E., Rossignol J., Brion R., Soulillou J.P., Anegon I., Cuturi M.C. A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood 2007, 110:3691-3694.
35. Nasef A., Mazurier C., Bouchet S., François S., Chapel A., Thierry D., Gorin N.C., Fouillard L. Leukemia inhibitory factor: Role in human mesenchymal stem cells mediated immunosuppression. Cell. Immunol. 2008, 253:16-22.
36. Gieseke F., Schütt B., Viebahn S., Koscielniak E., Friedrich W., Handgretinger R., Müller I. Human multipotent mesenchymal stromal cells inhibit proliferation of PBMCs independently of IFNgammaR1 signaling and IDO expression. Blood 2007, 110:2197-2200.
37. Gieseke F., Böhringer J., Bussolari R., Dominici M., Handgretinger R., Müller I. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood 2010, 116:3770-3779.
38. Sioud M., Mobergslien A., Boudabous A., Fløisand Y. Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins. Int. J. Oncol. 2011, 38:385-390.
39. Djouad F., Charbonnier L.M., Bouffi C., Louis-Plence P., Bony C., Apparailly F., Cantos C., Jorgensen C., Noël D. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6-dependent mechanism. Stem Cells 2007, 25:2025-2032.
40. Sato K., Ozaki K., Oh I., Meguro A., Hatanaka K., Nagai T., Muroi K., Ozawa K. Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood 2007, 109:228-234.
41. Liu J., Lu X.F., Wan L., Li Y.P., Li S.F., Zeng L.Y., Zeng Y.Z., Cheng L.H., Lu Y.R., Cheng J.Q. Suppression of human peripheral blood lymphocyte proliferation by immortalized mesenchymal stem cells derived from bone marrow of Banna Minipig inbred-line. Transplant. Proc. 2004, 36:3272-3275.
42. Augello A., Tasso R., Negrini S.M., Amateis A., Indiveri F., Cancedda R., Pennesi G. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur. J. Immunol. 2005, 35:1482-1490.
43. Dugast A.S., Vanhove B. Immune regulation by non-lymphoid cells in transplantation. Clin. Exp. Immunol. 2009, 156:25-34.
44. Batten P., Rosenthal N.A., Yacoub M.H. Immune response to stem cells and strategies to induce tolerance. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2007, 362:1343-1356.
45. Rasmusson I., Ringdén O., Sundberg B., Le Blanc K. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp. Cell Res. 2005, 305:33-41.
46. Hansen P.R., Rieneck K., Bendtzen K. Spironolactone inhibits production of proinflammatory cytokines by human mononuclear cells. Immunol. Lett. 2004, 91:87-91.
47. Weiss M.L., Medicetty S., Bledsoe A.R., Rachakatla R.S., Choi M., Merchav S., Luo Y., Rao M.S., Velagaleti G., Troyer D. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem Cells 2006, 24:781-792.